Skip to main content

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

 


The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period. This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth. 

Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive.

Download a free sample report now 👉
https://meditechinsights.com/multi-cancer-early-detection-market/request-sample/

Global cancer burden and the rising shift toward multi cancer early detection

The primary factor driving this market is the simple fact that cancer is still one of the leading causes of mortality around the world. According to an article published by the WHO, there were around 20 million new cases of cancer and 9.7 million deaths from cancer in the year 2022. The burden is expected to increase by 77% by 2050, and will further put more pressure on healthcare systems. The rising awareness about early detection of cancer and the surge in the number of cancer cases globally have spurred a major shift in screening methods. Instead of waiting for symptoms or relying on invasive, one cancer at a time tests, many healthcare providers are now leaning toward quicker, more inclusive methods like MCED, which requires a single blood draw and can check for multiple cancers, making it not just convenient but also more likely to get people screened in the first place. As clinical evidence continues to build and regulatory pathways evolve, these tests are poised to see much wider adoption in the years ahead.

DNA methylation profiling: a breakthrough enhancing test accuracy and adoption

cfDNA methylation profiling is one of the notable innovations making MCED more accurate and practical. Traditional screening methods include hunting for specific mutations; this test looks at how DNA is tagged with chemical markers called methylation which changes depending on the type and location of cancer. Even if there’s only a tiny amount of tumor DNA in the blood, these unique patterns can still be detected and used to trace the cancer’s origin. The test gives better precision, compared to other methods, meaning fewer false alarms and less need for stressful follow-up tests. The preliminary data for this test seems to be promising, due to which physicians are incorporating it in everyday preventive care, not just for early diagnosis, but for the entire conversation around cancer care. For instance, in February 2025, GRAIL partnered with Quest Diagnostics to make its Galleri test directly accessible to over 500,000 healthcare providers and 7,400 collection sites across the US through Quest Diagnostics' ordering system

Competitive Landscape Analysis

The global multi cancer early detection market is marked by the presence of established and emerging market players such Illumina, Inc.; GRAIL, Inc.; Exact Sciences Corporation; FOUNDATION MEDICINE, INC.; Guardant Health; Freenome Holdings, Inc; Elypta AB; AnchorDx and Burning Rock Biotech Limited among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Download a sample report for in-depth competitive insights
https://meditechinsights.com/multi-cancer-early-detection-market/request-sample/

 Global Multi Cancer Early Detection Market Segmentation

This report by Medi-Tech Insights provides the size of the global multi cancer early detection market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type and end-user.

Market Size & Forecast (2023-2030), By Type, USD Million

  • Liquid Biopsy
  • Gene Panel
  • LDT & Others

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals
  • Diagnostic Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:
Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more